Thursday preview: AstraZeneca and Unilever report

AstraZeneca and Unilever will take centre stage Thursday when the FTSE 100 companies reveal their first quarter results.

AstraZeneca and Unilever will take centre stage Thursday when the FTSE 100 companies reveal their first quarter results.

Drug giant AstraZeneca is expected to report an earnings per share of $1.41, compared to the group's consensus of $1.37, according to Panmure Research.

"The stock has significantly outperformed the market this year and investors should look to taking profits as we do not expect these results to be catalysts to further outperformance," the broker said, reiterating a 'hold' recommendation.

Earlier this month, the biopharmaceutical business announced positive results from a study of fostamatinib, an oral drug being developed for the treatment of rheumatoid arthritis.

In the phase III study, designed to assess the efficacy and safety of fostamatinib, the drug achieved a "statistically significant improvement" in the ACR20 [American College of Rhematology] response rate in patients compared to a placebo.

Meanwhile, Panmure anticipates Unilever will deliver a healthy 6.0% like-for-like growth in the first quarter, slightly ahead the 5.6% consensus.

The consumer goods company last year reported its highest growth quarter with an 8.4% like-for-like growth.

Panmure said an unseasonably cold European March was likely to have affected ice-cream sales but an early Easter will provide some benefit.

"Unilever remains our favourite large cap stock given its ability to deliver superior growth from its attractive emerging market positions, although we would like to see it find more acquisitions given the successes of Alberto Culver and Kalina," the analyst said. It recommended a 'buy' rating.

Thursday April 25th

INTERNATIONAL ECONOMIC ANNOUNCEMENTS

Bloomberg Consumer Confidence (US) (14:45)

Continuing Claims (US) (13:30)

Initial Jobless Claims (US) (13:30)

Q3

AstraZeneca, Banco Santander SA, Polski Koncern Naftowy Orlen S.A. GDR(Reg S), Unilever

GMS

European Assets Trust NV (Regd)

IMSS

Admiral Group, Aer Lingus Group, AZ Electronic Materials SA (DI), British American Tobacco, Namakwa Diamonds Ltd. (DI), Playtech Ltd., Senior

AGMS

Acencia Debt Strategies Ltd., Admiral Group, Aggreko, ARC Capital Holdings Ltd, AstraZeneca, Barclays, Berendsen, Biome Technologies. BlackRock World Mining Trust, British American Tobacco, COLT Group SA, Croda International, Dialight, DP World Limited, Electric Word, EP Global Opportunities Trust, European Assets Trust NV (Regd), Filtrona PLC, Forbidden Technologies, Guaranty Trust Bank GDR (Reg S), International Personal Finance, JPMorgan Claverhouse Inv Trust, Kimberly Enterprises NV, Kolar Gold Ltd., Powerflute Oyj (DI), Premier Foods, SpaceandPeople, Synety Group, Taylor Wimpey, Tomco Energy, Volkswagen AG, Wolfson Microelectronics

UK ECONOMIC ANNOUNCEMENTS

GDP (Preliminary) (09:30)

Index of Services (09:30)

FINAL DIVIDEND PAYMENT DATE

Anglo American, Maintel Holdings, Shore Capital Group Ltd.

Q1

AstraZeneca, Banco Santander SA, Polski Koncern Naftowy Orlen S.A. GDR(Reg S), Unilever

RD

Recommended

Anna Macdonald and Mikhail Zverev: Investing in innovative new frontiers
Investment strategy

Anna Macdonald and Mikhail Zverev: Investing in innovative new frontiers

Merryn talks to Anna Macdonald and Mikhail Zverev of Amati about investing in growth-focused innovation in the teeth of a tech-stock selloff, and the …
12 May 2022
BT is making progress and the dividend is back – but is it time to buy yet?
Share tips

BT is making progress and the dividend is back – but is it time to buy yet?

Investors in telecoms giant BT have seen dismal returns over the last 15 years. But there are signs that it is starting to turn things around, says Ru…
12 May 2022
Should you buy ITV shares as it takes on the digital streamers?
Share tips

Should you buy ITV shares as it takes on the digital streamers?

Broadcaster ITV is repositioning itself to take on the digital streaming platforms such as Netflix and Disney. Rupert Hargreaves looks at whether that…
11 May 2022
Centrica’s optimistic outlook does not make up for its growing challenges
Share tips

Centrica’s optimistic outlook does not make up for its growing challenges

Centrica, Britain's biggest energy supplier and owner of British Gas, looks to be on track to report a bumper performance for 2022, says Rupert Hargre…
10 May 2022

Most Popular

High inflation will fade – here’s why
Inflation

High inflation will fade – here’s why

Many people expect high inflation to persist for a long time. But that might not be true, says Max King. Inflation may fall faster than expected – and…
13 May 2022
Cryptocurrencies are crashing – so how low will bitcoin go?
Bitcoin & crypto

Cryptocurrencies are crashing – so how low will bitcoin go?

The entire cryptocurrency sector is crashing, with bitcoin now well below $30,000. This is big, says Dominic Frisby. So just how low could bitcoin go?
12 May 2022
What the Ukraine crisis might mean for ESG investing
Advertisement Feature

What the Ukraine crisis might mean for ESG investing

The Ukraine crisis has brought many of the issues around ESG investing into sharper focus. Where does the sector go from here?
3 May 2022